![]() ![]() “We can debride the joint and perhaps do some releases of some of the tissues that are contracted and get the patient some temporary relief by increasing the tolerances of the joint, but the long-term effect is limited because there is not any biology that you are changing in the structure,” Moorman told Orthopedics Today. Urbaniak, MD Sports Sciences Institute at Duke University. Moorman III, MD, who is professor and vice chair of the Department of Orthopedics and executive director of the James R. Mazzocca, MD, of UConn Health, discussed the regenerative potential of adult stem cells used in the shoulder, as well as treatment indications.Īthletes with an intramuscular pectoralis tear or another muscle injury may benefit from stem cells as may patients with early shoulder arthritis, according to Claude T. Laurencin, MD, PhD, (left) and Augustus D. What is lacking is the biologic environment to help heal the rotator cuff and that is where stem cells, platelet-rich plasma (PRP) and biologic factors have been associated to hopefully improve healing rates, improve patient satisfaction and improve postoperative strength and function,” said Weber, who is assistant professor at the University of Southern California Department of Orthopedic Surgery, Section of Sports Medicine and Shoulder Surgery. “We now know we have the surgical techniques and equipment to robustly tack down the rotator cuff tendon back to the bone so the mechanical environment is strong. “One way to ideally improve rotator cuff healing rates is to augment the mechanical repair that we do, whether it be a double-row repair, a single-row repair or a transosseous equivalent type repair, with some biologic activity to help promote healing,” Alexander E. Ultimately, this may mean some patients will need to undergo a traditional treatment later, and thereby withstand two or more treatments for the same condition, sources said. In addition, the effectiveness of cell therapy for these indications is largely unproven. Stem cells injected in the shoulder or introduced during arthroscopic or open surgery, for example, can be costly and may not be covered by many insurance plans. The stem cell treatment approach is controversial, according to sources who spoke with Orthopedics Today. This includes exploring the effect in the laboratory and the OR of various types of stem cells on healing when injected or used to augment arthroscopic or open surgery. Therefore, research into biologic treatments for these conditions is underway. It is widely known and reported in the literature that shoulder injuries, including rotator cuff tears, tend to heal slowly and the management of glenoid labral tears, subacromial impingement and the degenerative, arthritic shoulder may be challenging. If you continue to have this issue please contact to Healio
0 Comments
Leave a Reply. |